LLY

928.56

+2.46%↑

JNJ

186.29

-0.27%↓

UNH

327.86

-0.81%↓

NVS

125.19

+0.06%↑

ABT

124.68

-0.87%↓

LLY

928.56

+2.46%↑

JNJ

186.29

-0.27%↓

UNH

327.86

-0.81%↓

NVS

125.19

+0.06%↑

ABT

124.68

-0.87%↓

LLY

928.56

+2.46%↑

JNJ

186.29

-0.27%↓

UNH

327.86

-0.81%↓

NVS

125.19

+0.06%↑

ABT

124.68

-0.87%↓

LLY

928.56

+2.46%↑

JNJ

186.29

-0.27%↓

UNH

327.86

-0.81%↓

NVS

125.19

+0.06%↑

ABT

124.68

-0.87%↓

LLY

928.56

+2.46%↑

JNJ

186.29

-0.27%↓

UNH

327.86

-0.81%↓

NVS

125.19

+0.06%↑

ABT

124.68

-0.87%↓

Search

Pfizer

Chiusa

SettoreSettore sanitario

24.59 1.15

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

24.16

Massimo

24.66

Metriche Chiave

By Trading Economics

Entrata

-45M

2.9B

Vendite

938M

15B

P/E

Media del settore

13.048

77.256

EPS

0.51

Rendimento da dividendi

6.9

Margine di Profitto

19.982

Dipendenti

81,000

EBITDA

266M

5.3B

Raccomandazioni

By TipRanks

Raccomandazioni

Neutrale

Previsioni per 12 mesi

+18.77% upside

Dividendi

By Dow Jones

Rendimento da dividendi

Media del settore

6.90%

2.33%

Prossima data del Dividendo

1 dic 2025

Prossima data del' Ex Dividendo

7 nov 2025

Statistiche di mercato

By TradingEconomics

Capitalizzazione di Mercato

6.4B

140B

Apertura precedente

23.44

Chiusura precedente

24.59

Notizie sul Sentiment di mercato

By Acuity

50%

50%

165 / 374 Classifica in Healthcare

Punteggio Tecnico

By Trading Central

Fiducia

Bullish Evidence

Pfizer Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

5 nov 2025, 22:44 UTC

Acquisizioni, Fusioni, Takeovers

Pfizer Preps Improved Offer in Metsera Bidding War -- Update

5 nov 2025, 22:12 UTC

Acquisizioni, Fusioni, Takeovers

Pfizer: Will Take Action to Preserve Rights Under Previously-Signed Agreement >PFE

5 nov 2025, 22:11 UTC

Acquisizioni, Fusioni, Takeovers

Pfizer: Confident in Merits of Claims, Belief Metsera Has Acted in Breach of Contractual Obligations >PFE

5 nov 2025, 22:11 UTC

Acquisizioni, Fusioni, Takeovers

Pfizer Responds to Delaware Chancery Court Ruling

5 nov 2025, 21:52 UTC

Acquisizioni, Fusioni, Takeovers

Pfizer Plans to Deliver Bid Wednesday, Sources Say -- WSJ

5 nov 2025, 21:52 UTC

Acquisizioni, Fusioni, Takeovers

Novo Nordisk Recently Offered Up to $10B for Metsera -- WSJ

5 nov 2025, 21:52 UTC

Acquisizioni, Fusioni, Takeovers

Pfizer Preps Improved Offer in Metsera Bidding War -- WSJ

5 nov 2025, 21:52 UTC

Acquisizioni, Fusioni, Takeovers

Pfizer Preparing New Bid for Metsera, Sources Say -- WSJ

5 nov 2025, 15:43 UTC

Utili

Novo Nordisk Stock Falls After Earnings. It Cut Guidance on These Fears. -- Barrons.com

5 nov 2025, 13:06 UTC

Utili

Novo Nordisk Stock Falls After Earnings. It Cut Guidance on These Fears. -- Barrons.com

5 nov 2025, 12:30 UTC

Acquisizioni, Fusioni, Takeovers

Novo Nordisk Stock Rises After Earnings. It Cut Guidance on These Fears. -- Barrons.com

5 nov 2025, 10:00 UTC

Utili

Novo Nordisk Stock Up After Earnings. Guidance Cut on These Weight-Loss Drug Fears. -- Barrons.com

4 nov 2025, 22:10 UTC

Acquisizioni, Fusioni, Takeovers

Pfizer, Novo Nordisk Escalate Bidding War for Weight-Loss Drug Startup -- 2nd Update

4 nov 2025, 19:39 UTC

Acquisizioni, Fusioni, Takeovers

Pfizer, Novo Nordisk Escalate Bidding War for Weight-Loss Drug Startup -- Update

4 nov 2025, 18:35 UTC

Acquisizioni, Fusioni, Takeovers

Novo Nordisk Is Still Beating Pfizer in Battle Over Metsera -- Barrons.com

4 nov 2025, 18:11 UTC

Utili

Pfizer 3Q Profit Falls Amid Lower Covid-19 Drug Demand -- 2nd Update

4 nov 2025, 17:59 UTC

Utili

Pfizer Stock Slips. Under the Surface, Earnings Weren't Great. -- Barrons.com

4 nov 2025, 17:26 UTC

Acquisizioni, Fusioni, Takeovers

Novo Nordisk Is Still Beating Pfizer in Battle Over Metsera -- Barrons.com

4 nov 2025, 16:01 UTC

Acquisizioni, Fusioni, Takeovers

Pfizer, Novo Nordisk Escalate Bidding War for Weight-Loss Drug Startup -- WSJ

4 nov 2025, 15:17 UTC

Acquisizioni, Fusioni, Takeovers

Novo Nordisk and Pfizer Sweeten Their Offers for Weight-Loss Drug Startup Metsera -- WSJ

4 nov 2025, 14:58 UTC

Acquisizioni, Fusioni, Takeovers

Novo Nordisk Sweetens Offer for Metsera -- WSJ

4 nov 2025, 14:37 UTC

Acquisizioni, Fusioni, Takeovers

Novo Nordisk: Proposal Is Subject to Terms of Pfizer's Merger Pact With Metsera

4 nov 2025, 14:35 UTC

Acquisizioni, Fusioni, Takeovers

Novo Nordisk Says Offer Highlights Commitment to Investing in U.S., Interest in Growing Scale of U.S. Investments

4 nov 2025, 14:34 UTC

Acquisizioni, Fusioni, Takeovers

Novo Nordisk Believes Proposal, Including Structure, Complies With Applicable Laws and Is in Best Interest of Patients

4 nov 2025, 14:33 UTC

Acquisizioni, Fusioni, Takeovers

Novo Nordisk Offers $62.20 a Share in Cash and Up to $24 a Share Based on Certain Milestones

4 nov 2025, 14:32 UTC

Acquisizioni, Fusioni, Takeovers

Novo Nordisk Confirms Updated Bid For Metsera

4 nov 2025, 14:12 UTC

Acquisizioni, Fusioni, Takeovers

Metsera Says Pfizer Merger Agreement Remains in Effect >MTSR

4 nov 2025, 14:12 UTC

Acquisizioni, Fusioni, Takeovers

Metsera, Pfizer May Negotiate Potential Adjustments for Two Business Days >MTSR

4 nov 2025, 14:12 UTC

Acquisizioni, Fusioni, Takeovers

Metsera: Novo Nordisk Offer Superior to Revised Pfizer Proposal That Valued It at Up to $ 70/Shr, a Total of About $8.1B >MTSR

4 nov 2025, 14:11 UTC

Acquisizioni, Fusioni, Takeovers

Metsera: Novo Nordisk's Amended Proposal Values It at Up to $ 86.20/Shr, a Total of About $ 10.0B >MTSR

Confronto tra pari

Modifica del prezzo

Pfizer Previsione

Obiettivo di Prezzo

By TipRanks

18.77% in crescita

Previsioni per 12 mesi

Media 28.86 USD  18.77%

Alto 34 USD

Basso 24 USD

Basato su 16 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per Pfizer - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Neutrale

16 ratings

4

Acquista

11

Mantieni

1

Vendi

Punteggio Tecnico

By Trading Central

22.855 / 23.85Supporto e resistenza

A breve termine

Bullish Evidence

A termine intermedio

Bearish Evidence

A lungo termine

Bearish Evidence

Sentiment

By Acuity

165 / 374 Classifica in Settore sanitario

Notizie sul Sentiment di mercato

Neutral

Volatilità

Sotto la media

Volume delle notizie (RCV)

Sopra la media

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

$

Chi Siamo Pfizer

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. It also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Litfulo, Velsipity, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, Somavert, Ngenla, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Inlyta, Bosulif, Mektovi, Padcev, Adcetris, Talzenna, Tukysa, Elrexfio, Tivdak, Lorbrena, and Braftovi brands. In addition, the company involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE, as well as has strategic clinical collaboration with Acepodia Inc. for the development of antibody-cell conjugation-based cell therapies in autoimmune diseases. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
help-icon Live chat